Zurcher Kantonalbank (Zurich Cantonalbank) Igm Biosciences, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$13.42 - $29.73 $9,004 - $19,948	-671 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$27.59 - $66.39 $1,931 - $4,647	-70 Reduced 9.45%	671 $20,000
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $263 - $362	4 Added 0.54%	741 $49,000
Q2 2021 Jul 30, 2021	BUY	$57.98 - $96.6 $2,956 - $4,926	51 Added 7.43%	737 $61,000
Q1 2021 May 03, 2021	BUY	$71.56 - $121.23 $49,090 - $83,163	686 New	686 $53,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

Baker Bros. Advisors LP New York, NY

4.09M
Shares

$26.6 Million
0.72% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.01M
Shares

$26.1 Million
0.01% of portfolio
Siren, L.L.C. New York, NY

3.33M
Shares

$21.7 Million
2.75% of portfolio
Redmile Group, LLC San Francisco, CA

3.07M
Shares

$20 Million
3.32% of portfolio
Goldman Sachs Group Inc New York, NY

1.26M
Shares

$8.2 Million
0.0% of portfolio

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account